SEB Asset Management AB »

Miragen Therapeutics shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.1M 157k 19.56

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
Bellevue Group
Vanguard Capital Management
Fairmount Funds Management
VR Adviser
State Street Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Kynam Capital Management
Geode Capital Management
Balyasny Asset Management
Novo A/S
Baker Bros. Advisors

View all funds holding Miragen Therapeutics